The treatment landscape for multiple sclerosis continues to evolve as pharmaceutical companies invest heavily in advanced therapies, personalized medicine, and digital healthcare solutions. Rising disease awareness, improved diagnostic capabilities, and growing access to disease-modifying treatments are contributing to sustained industry expansion across major regions. The Multiple Sclerosis...